Dr Jannatul Ferdoush Tuli

Clinical Trials Research Officer

Adelaide Medical School

Faculty of Health and Medical Sciences


Dr Jannatul Ferdoush TuliClinical Researcher,Rheumatology Research group

Highly skilled in clinical trial coordination and research, I bring comprehensive expertise in Biobanking, ethics submission, coordination, recruitment, and meticulous analysis. My adeptness extends to supporting trial design and protocol development, bolstered by a strong background in laboratory techniques encompassing cell and tissue culture, Microbiology, mass spectrometry, and sequencing. Currently at the helm of the SA-node of the Australian Arthritis and Autoimmune Biobank Collaborative (A3BC) and co-ordinate The PROSPECT trial: PRedicting disease-mOdifying anti-rheumatic drug doSe reduction response in rheumatoid and Psoriatic arthritis with EConomic evaluation, my management is coupled with hands-on proficiency. With a track record of impactful publications in different scientific journals, I remain dedicated to advancing medical research.

Date Position Institution name
2022 - ongoing Clinical Trial Research Officer The University of Adelaide

Date Type Title Institution Name Country Amount
2021 Award The Bertha Sudholz Research Scholarship The university of Adelaide Australia 5000
2016 Scholarship Autralian Postgraduate Research Scholarship University of Adelaide Australia -

Language Competency
Bengali Can read, write, speak, understand spoken and peer review
English Can read, write, speak, understand spoken and peer review

Date Institution name Country Title
2023 - 2023 The University of Dhaka Bangladesh Bachelor of Science in Genetic Engineering and Biotechnology
2020 - 2023 The University of Adelaide Australia PhD
2010 - 2011 The University of Dhaka Bangladesh Masters of Sciences in Genetic Engineering and Biotechnology

Year Citation
2024 Tuli, J. F., Ramezanpour, M., Cooksley, C., Bouras, G. S., Ogi, K., Feizi, S., . . . Vreugde, S. (2024). Increased antibiotic resistance of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients grown in anaerobic conditions. Laryngoscope Investigative Otolaryngology, 9(3), e1244-1-e1244-9.
DOI Scopus2 WoS3 Europe PMC4
2021 Tuli, J. F., Ramezanpour, M., Cooksley, C., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2021). Association between mucosal barrier disruption by Pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis.. Allergy, 76(11), 3459-3469.
DOI Scopus30 WoS27 Europe PMC24
2021 Ramezanpour, M., Ogi, K., Liu, S., Tuli, J. F., Bennett, C., Masanobu, S., . . . Vreugde, S. (2021). Der p 1 disrupts the epithelial barrier and induces IL-6 production in patients with house dust mite allergic rhinitis. Frontiers in Allergy, 2, 692049-1-692049-9.
DOI Scopus17 WoS15 Europe PMC13
2015 Leifert, W., Tuli, J., Francois, M., Nguyen, T., Rembach, A., Rumble, R., . . . Fenech, M. (2015). Buccal cell cytokeratin 14 identifies mild cognitive impairment and alzheimer's disease in the aibl study of aging. Current Alzheimer Research, 12(3), 233-241.
DOI Scopus10 WoS9 Europe PMC8
2015 Najnin, R. A., Shafrin, F., Polash, A. H., Zaman, A., Hossain, A., Taha, T., . . . Khan, H. (2015). A diverse community of jute (Corchorus spp.) endophytes reveals mutualistic host–microbe interactions. Annals of Microbiology, 65(3), 1615-1626.
DOI Scopus11 WoS11

Connect With Me

External Profiles

Other Links